← Back to headlines
Novo Nordisk and UPL Announce Board Nominations and Scheme of Arrangement
Novo Nordisk has nominated new members to its board, while UPL has approved a composite scheme of arrangement, indicating corporate governance and structural changes within these companies.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
